Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Afamelanotide

EU orphan designation number: EU/3/09/648   
Active ingredient: Afamelanotide
Indication: Treatment of solar urticaria
Sponsor: Clinuvel (UK) Limited
C/o- Reed Smith, Broadgate Tower, Third Floor, 20 Primrose Street, London, EC2A 2RS, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
30/07/2009 Centralised Orphan - Designation EMEA/OD/019/09 (2009)6075 of 24/07/2009